Literature DB >> 29770484

Inter-method reproducibility of biexponential R2 MR relaxometry for estimation of liver iron concentration.

Ali Pirasteh1, Qing Yuan1, Diego Hernando2, Scott B Reeder3, Ivan Pedrosa1,4, Takeshi Yokoo1,4.   

Abstract

PURPOSE: To assess the reproducibility of biexponential R2 -relaxometry MRI for estimation of liver iron concentration (LIC) between proprietary and nonproprietary analysis methods.
METHODS: This single-center retrospective study, approved by investigational review board and compliant with the Health Insurance Portability and Accountability Act, included 40 liver MRI exams in 38 subjects with suspected or known iron overload. From spin-echo images of the liver, acquired at 5 different echo times (TE = 6-18 ms), biexponential R2 maps were calculated using 1 proprietary (FerriScan, Resonance Health Ltd., Claremont WA, Australia) and 3 nonproprietary (simulated annealing, nonlinear least squares, dictionary search) analysis methods. Each subject's average liver R2 value was converted to LIC using a previously validated calibration curve. Inter-method reproducibility for liver R2 and LIC were assessed for linearity using linear regression analysis and absolute agreement using intraclass correlation and Bland-Altman analysis. For point estimates, 95% confidence intervals were calculated; P values < 0.05 were considered statistically significant.
RESULTS: Linearity between the proprietary and nonproprietary methods was excellent across the observed range for R2 (20-312 s-1 ) and LIC (0.4-52.2 mg/g), with all coefficients of determination (R2 ) ≥ 0.95. No statistically significant bias was found (slope estimates ∼ 1; intercept estimates ∼ 0; P values > 0.05). Agreement between the 4 methods was excellent for both liver R2 and LIC (intraclass correlations ≥ 0.97). Bland-Altman 95% limits of agreement in % difference between the proprietary and nonproprietary methods were ≤ 9% and ≤ 16% for R2 and LIC, respectively.
CONCLUSION: Biexponential R2 -relaxometry MRI for LIC estimation is reproducible between proprietary and nonproprietary analysis methods.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  R2 relaxation; T2 relaxation; hemochromatosis; hemosiderosis; iron overload; liver iron concentration; reproducibility

Mesh:

Substances:

Year:  2018        PMID: 29770484      PMCID: PMC6239995          DOI: 10.1002/mrm.27348

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  27 in total

Review 1.  Secondary iron overload.

Authors:  J P Kushner; J P Porter; N F Olivieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

2.  Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver.

Authors:  Paul R Clark; Wanida Chua-anusorn; Timothy G St Pierre
Journal:  Magn Reson Imaging       Date:  2003-06       Impact factor: 2.546

3.  Reduction of respiratory motion artifacts in transverse relaxation rate (R2) images of the liver.

Authors:  Paul R Clark; Wanida Chua-anusorn; Timothy G St Pierre
Journal:  Comput Med Imaging Graph       Date:  2004 Jan-Mar       Impact factor: 4.790

Review 4.  Single spin-echo proton transverse relaxometry of iron-loaded liver.

Authors:  Timothy G St Pierre; Paul R Clark; Wanida Chua-Anusorn
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

5.  Variability in hepatic iron concentration measurement from needle-biopsy specimens.

Authors:  J P Villeneuve; M Bilodeau; R Lepage; J Côté; M Lefebvre
Journal:  J Hepatol       Date:  1996-08       Impact factor: 25.083

6.  Measurement of iron in liver biopsies--a comparison of three analytical methods.

Authors:  H G Kreeftenberg; B J Koopman; J R Huizenga; T van Vilsteren; B G Wolthers; C H Gips
Journal:  Clin Chim Acta       Date:  1984-12-29       Impact factor: 3.786

Review 7.  Natural history and management of HFE-hemochromatosis.

Authors:  Eng K Gan; Lawrie W Powell; John K Olynyk
Journal:  Semin Liver Dis       Date:  2011-09-07       Impact factor: 6.115

Review 8.  Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.

Authors:  G D McLaren; W A Muir; R W Kellermeyer
Journal:  Crit Rev Clin Lab Sci       Date:  1983       Impact factor: 6.250

9.  Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.

Authors:  F Nolte; B Höchsmann; A Giagounidis; M Lübbert; U Platzbecker; D Haase; A Lück; N Gattermann; M Taupitz; M Baier; O Leismann; A Junkes; C Schumann; W K Hofmann; H Schrezenmeier
Journal:  Ann Hematol       Date:  2012-10-17       Impact factor: 3.673

10.  Magnetic resonance fingerprinting.

Authors:  Dan Ma; Vikas Gulani; Nicole Seiberlich; Kecheng Liu; Jeffrey L Sunshine; Jeffrey L Duerk; Mark A Griswold
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

View more
  3 in total

1.  MRI liver fat quantification in an oncologic population: the added value of complex chemical shift-encoded MRI.

Authors:  Giuseppe Corrias; Simone Krebs; Sarah Eskreis-Winkler; Davinia Ryan; Junting Zheng; Marinela Capanu; Luca Saba; Serena Monti; Maggie Fung; Scott Reeder; Lorenzo Mannelli
Journal:  Clin Imaging       Date:  2018-08-08       Impact factor: 1.605

2.  A novel gamma GLM approach to MRI relaxometry comparisons.

Authors:  Rohan Kapre; Junhan Zhou; Xinzhe Li; Laurel Beckett; Angelique Y Louie
Journal:  Magn Reson Med       Date:  2020-02-12       Impact factor: 4.668

3.  Abdominal magnetic resonance imaging examination of Tibetan patients with abnormal iron metabolism and a preliminary study of correlations with blood cell analysis.

Authors:  Yi Zhou; Jin-Li Meng; Li Feng; Yong-Hong Huang; Jin Ye; Man Li; Zhong-You Xu; Xiang-Wei Li; Fang Yuan; Bin Song
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.